Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 988 of 1,261
  1. CA 2754902

    COMPOSES D'ACIDE GRAS ESSENTIEL

    AMARIN NEUROSCIENCE LTD [GB] · Granted Sep 16, 2010 · Expires Sep 11, 2030

    granted
  2. US 7795495

    Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them

    The Regents of the University of California · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  3. US 7795305

    CDDO-compounds and combination therapies thereof

    The Board of Regents of the University of Texas System · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  4. US 7795428

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  5. US 7795208

    Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  6. US 7794717

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  7. US 7794714

    Newcastle disease virus monoclonal antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  8. US 7795274

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  9. US 7795300

    External preparation for skin

    KURARAY CO., LTD. · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  10. US 7795295

    Small molecule inhibition of PDZ-domain interaction

    The Regents of the University of California · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  11. US 7795267

    Bicyclic piperazine compound having TGR23 antagonistic activity

    Takeda Pharmaceutical Company Limited · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  12. US 7795259

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  13. US 7795209

    Anti-angiogenic methods and compositions

    Sangamo Biosciences, Inc. · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  14. US 7794998

    Primate T-lymphotropic viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  15. US 7794734

    Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever

    The Board of Regents for Oklahoma State University · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  16. US 7794726

    Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use

    The Boards of Regents of the University of Oklahoma · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  17. US 7794730

    Polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish

    East China University of Science and Technology · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  18. US 7794728

    Attenuated Listeria spp. and methods for using the same

    The Regents of the University of California · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  19. US 7795302

    Use of compositions for treating rosacea

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  20. US 7795389

    Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins

    The Board of Regents of the University of Texas System · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  21. US 7795386

    Peptides comprising an isoDGR motif

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  22. US 7794957

    Eukaryotic genes involved in adult lifespan regulation

    The Regents of the University of California · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  23. AU 2009200642

    Method using enoxaparin for reducing the risk of death in acutely ill medical patients

    AVENTIS PHARMA SA [FR] · Granted Sep 9, 2010 · Expires Sep 4, 2030

    granted
  24. US 7790899

    Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms

    ACADIA Pharmaceuticals Inc. · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.